Biotech & Pharmaceuticals Post-Brexit
Alacrita consulting released an infographic detailing insight from leaders in the pharma and biotech industries and what their predictions are for a post-Brexit market. Survey results indicate what’s to come for leaders and industry players and how attitudes are predicting to change.
Some of the findings may come as a surprise for some, while other results can only be confirmed with time. For example, 98 percent of pharma execs say that Europe is an important market for their products. At the end of the day, the environment for clinical research, pharma companies and products could very well take a substantial shift.
Provided by Alacrita
Sigfox Introduces Canada’s First Ever National IoT Network